Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis B. Rice

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2018
A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective EndocarditisMaya Beganovic, Megan K Luther, Louis B Rice, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniaeLouis B Rice, Lenore L Carias, Rebecca A Hutton, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faeciumMónica García-Solache, Francois Lebreton, Robert E McLaughlin, et al.
Journal of Microbiological Methods|June 5, 2003
Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patientsCurtis J Donskey, Andrea M Hujer, Sarbani M Das, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristinIssam I Raad, Hend A Hanna, Ray Y Hachem, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide AntibioticsGeorge Sakoulas, Monika Kumaraswamy, Poochit Nonejuie, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2022
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an <i>In Vitro</i> Pharmacodynamic Model Using Humanized Dosing SimulationsJaclyn A Cusumano, Kathryn E Daffinee, Emily C Piehl, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesDavid L Paterson, Kristine M Hujer, Andrea M Hujer, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistinAndrea Endimiani, Gopi Patel, Kristine M Hujer, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faeciumEmmanuelle Sacco, Mélanie Cortes, Nathalie Josseaume, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2018
A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective EndocarditisMaya Beganovic, Megan K Luther, Louis B Rice, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2008
The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniaeLouis B Rice, Lenore L Carias, Rebecca A Hutton, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2016
Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faeciumMónica García-Solache, Francois Lebreton, Robert E McLaughlin, et al.
Journal of Microbiological Methods|June 5, 2003
Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patientsCurtis J Donskey, Andrea M Hujer, Sarbani M Das, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristinIssam I Raad, Hend A Hanna, Ray Y Hachem, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide AntibioticsGeorge Sakoulas, Monika Kumaraswamy, Poochit Nonejuie, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2022
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an <i>In Vitro</i> Pharmacodynamic Model Using Humanized Dosing SimulationsJaclyn A Cusumano, Kathryn E Daffinee, Emily C Piehl, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesDavid L Paterson, Kristine M Hujer, Andrea M Hujer, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2009
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistinAndrea Endimiani, Gopi Patel, Kristine M Hujer, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Mutation landscape of acquired cross-resistance to glycopeptide and β-lactam antibiotics in Enterococcus faeciumEmmanuelle Sacco, Mélanie Cortes, Nathalie Josseaume, et al.
Pageof 10